Rapamycin: Easter Island's fountain of youth?
What a drug that makes mice live longer could do for humans
Scientists haven't found the fountain of youth, said Keith J. Winstein in The Wall Street Journal, and you won't be able to buy a "reliable human longevity pill" any time soon. But a study published Wednesday in the journal Nature "found that rapamycin, a drug used in organ transplants, increased the life span of mice by 9 percent to 14 percent, the first definitive case in which a chemical has been shown to extend the life span of normal mammals."
Another promising aspect of the find, said Gisela Telis in Science, was that the antibiotic rapamycin—first found in soil samples from Easter Island in 1965—"enabled middle-aged mice to live up to 16 percent longer than their rapa-free counterparts." That doesn't make rapamycin the fountain of youth, but the discovery marks the first time a drug has been shown to lengthen life span in mammals, even when administered late in life."
That's encouraging, said Nicholas Wade in The New York Times, because "other interventions that prolong life in mice, including a very low-calorie diet, need to be started early in life to show any effect." But doctors warn that rapamycin can have dangerous side effects—it is used to suppress the immune system in transplant patients. A drug like that is "not to be trifled with," so don't try this at home.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
EastEnders at 40: are soaps still relevant?
Talking Point Albert Square's residents are celebrating, but falling viewer figures have fans worried the soap bubble has burst
By Elizabeth Carr-Ellis, The Week UK Published
-
What will the thaw in Russia-US relations cost Europe?
Today's Big Question US determination to strike a deal with Russia over Ukraine means Europe faces 'betrayal by a long-term ally'
By Richard Windsor, The Week UK Published
-
Why Spain's economy is booming
The Explainer Immigration, tourism and cheap energy driving best growth figures in Europe
By The Week UK Published